CLINICAL_TRIALS
trial_result
· 2024-11-21
Clinical Trial Update: Primaquine Enantiomers in G6PD Deficient Human Volunteers [Phase 1]
Summary
Phase 1 trial evaluating primaquine enantiomers in G6PD-deficient human volunteers has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Mississippi, Oxford | Conditions: G6PD Deficiency | Phase 1 | Status: COMPLETED